Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

New data at ENS show Novartis drug Gilenya benefited patients by improving all four key measures of multiple sclerosis
MS related employment and disease modifying treatment in the German working population: 1994-2009.
Sublime Microglia: Expanding Roles for the Guardians of the CNS.
Does glatiramer acetate provoke hepatitis in multiple sclerosis?
Sleep Disorders and Multiple Sclerosis: A Clinical and Polysomnography Study.
Evaluation of sexual function in women at two stages of multiple sclerosis.
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.
JC-virus seroconversion in multiple sclerosis patients receiving natalizumab.
Early pathological alterations of lower lumbar cords detected by ultrahigh-field MRI in a mouse multiple sclerosis model.
Birth outcomes of pregnancies fathered by men with multiple sclerosis.
Bayer Receives FDA Approval for BETACONNECT - First and Only Electronic Autoinjector in Relapsing-Remitting Multiple Sclerosis (RRMS) Treatment
Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity.
Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosis.
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
Improving Hand Functional Use in Subjects with Multiple Sclerosis Using a Musical Keyboard: A Randomized Controlled Trial.
Microbial colonization influences early B-lineage development in the gut lamina propria.
Infectious causes of multiple sclerosis.
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.
The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.
[Vitamin D for prevention of diseases?].
Incidence of multiple sclerosis in Northern Lisbon, Portugal: 1998¿2007.
Teva to initiate third Phase III trial of oral laquinimod for the treatment of relapsing remitting multiple sclerosis
Fatigue in multiple sclerosis - A brief review.
Nav1.5 sodium channels in macrophages in multiple sclerosis lesions.
Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis.

Pages